Why Is BAUSCH HEALTH COS IN (BHC) Stock Up Today?

BHC stock rose 5.17% to $6.92 in the session, driven by a combination of strong earnings and sales results, as well as a bullish call volume. The stock opened at $6.53, below the prior close of $6.58, but climbed steadily to a high of $6.93 before settling at $6.92. The move followed the company's announcement of its 2026 Gastrointestinal Health Scholars Program and a revised sales guidance for the year.

What Happened

Bausch Health reported Q2 adjusted earnings per share of $1.26, surpassing the estimated $1.04, and sales of $2.852 billion, exceeding the estimated $2.661 billion. These results contributed to the upward movement in the stock. Additionally, the company announced the winners of its 2026 Gastrointestinal Health Scholars Program, awarding $10,000 scholarships to 10 students for the seventh consecutive year. This news, combined with a raised FY2026 sales guidance to a range of $10.790 billion to $11.040 billion, reinforced investor confidence. The Fly reported that call volume for the stock was above normal and directionally bullish, indicating strong short-term demand.

What The Data Shows

The stock traded at $6.92, with a volume of 0.9 million shares, which is 0.3 times the 3-month daily average. The price action showed a gap down at the open but quickly reversed to a positive trend. The stock reached a session high of $6.93 at 11:20 AM ET. It has a market cap of $2.2 billion, a revenue increase of 10.1% in the trailing twelve months, and a net margin of -10.1%. The stock is currently trading within its 52-week range of $4.33 to $8.69. On August 18, 2026, the stock printed one fresh 52-week low and 10 fresh 52-week highs.

What To Watch

Investors should continue to monitor the company's upcoming earnings report and any further guidance updates. The stock's performance may also be influenced by broader market trends and sector-specific developments.